Form 8-K - Current report:
SEC Accession No. 0001213900-26-048252
Filing Date
2026-04-28
Accepted
2026-04-28 07:31:38
Documents
12
Period of Report
2026-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0287845-8k_pmgc.htm   iXBRL 8-K 26906
2 PRESS RELEASE DATED APRIL 28, 2026 ea028784501ex99-1.htm EX-99.1 7947
  Complete submission text file 0001213900-26-048252.txt   202997

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20260428.xsd EX-101.SCH 3026
4 XBRL LABEL FILE elab-20260428_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE elab-20260428_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0287845-8k_pmgc_htm.xml XML 3205
Mailing Address 120 NEWPORT CENTER DRIVE NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 26903149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)